Document Detail

The management of premature labor with salbutamol.
MedLine Citation:
PMID:  7025554     Owner:  NLM     Status:  MEDLINE    
One hundred and eight patients with imminent premature labor in the 24-36th week of pregnancy and with intact membranes were allocated randomly to two groups. Fifty-four patients were treated with intravenous infusion of 12-50 microgram/min of salbutamol (Ventoline) and 4 mg was subsequently given orally at 4-hour intervals. The weight of the newborn was over 2 500 g in 72% of cases. The duration of pregnancy was prolonged by over seven days in 67%, and 37 weeks of pregnancy and more was achieved in 61%. The comparable figures for the control group treated with fenoterol, 3-4 microgram/min and subsequently 5 mg orally at 4-hour intervals, were 78, 80 and 70% respectively.
M Gummerus
Related Documents :
7485324 - Does magnesium sulfate affect the length of labor induction in women with pregnancy-ass...
3534134 - Oxytocin: pharmacology and clinical application.
1951564 - Systemic administration of interleukin-1 induces preterm parturition in mice.
6591604 - Chronic myelocytic leukemia in pregnancy: report of a case treated with leukapheresis.
10560074 - Measurement of the amniotic fluid index with and without color doppler.
3517724 - Fetal biophysical profile and the effect of premature rupture of the membranes.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Acta obstetricia et gynecologica Scandinavica     Volume:  60     ISSN:  0001-6349     ISO Abbreviation:  Acta Obstet Gynecol Scand     Publication Date:  1981  
Date Detail:
Created Date:  1981-11-18     Completed Date:  1981-11-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370343     Medline TA:  Acta Obstet Gynecol Scand     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  375-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Albuterol / therapeutic use*
Clinical Trials as Topic
Fenoterol / therapeutic use
Gestational Age
Infusions, Parenteral
Obstetric Labor, Premature / prevention & control*
Random Allocation
Reg. No./Substance:
13392-18-2/Fenoterol; 18559-94-9/Albuterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of muscular exercise and metabolic control on cortisol, growth hormone, plasma-epinephrine an...
Next Document:  Torsional strength of cortical and cancellous bone grafts after rigid plate fixation.